磐九鼎
2020-03-06

$NanoViricides Inc.(NNVC)$Management intends to conduct initial testing of its drug candidates in its own virology laboratory using low-threat coronavirus strains that have been normally circulating in the human population. If successful, it has the ability to make "kilogram quantities" in just a few weeks which, it says, would be sufficient to treat several hundred to a few thousand patients.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • 理想不是梦
    2020-03-06
    理想不是梦
    测试计划,就算好消息啊
    • 磐九鼎Reply理想不是梦
      做空需要谨慎,和疫情已经更紧关联了,大背景下会提供更加便利的临床病人以及省去ind等繁琐手续
    • 理想不是梦
      可否做空?
    • 磐九鼎
      说明能拿到病株,也说明和美国医院和机构合作上了
    • 磐九鼎Reply理想不是梦
      做空需谨慎,这家在禽流感和sars均有多年研究和积累,候选药物还是有不错的概率,现在的疫情背景可以加速临床和省去ind各种繁琐手续。真正有能力的直接时代造就英雄
  • 磐九鼎
    2020-03-06
    磐九鼎
    管理层打算在自己的病毒学实验室使用在人群中正常传播的低威胁冠状病毒株对候选药物进行初步测试。如果成功的话,它有能力在几周内制造出“千克数量”,它说,这足以治疗几百到几千名患者。
  • zhouronghoo
    2020-03-06
    zhouronghoo
    我现在感觉他能到40了
  • 韭菜叶
    2020-03-06
    韭菜叶
    治疗方法终于有进展了[捂脸]
Leave a comment
8